Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 180

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease

Open access
Hung, Lin W., Villemagne, Victor L., Cheng, Lesley, Sherratt, Nicki A., Ayton, Scott, White, Anthony R., Crouch, Peter J., Lim, SinChun, Leong, Su Ling, Wilkins, Simon, George, Jessica, Roberts, Blaine R., Pham, Chi L.L., Liu, Xiang, Chiu, Francis C.K., Shackleford, David M., Powell, Andrew K., Masters, Colin L., Bush, Ashley I., O’Keefe, Graeme, Culvenor, Janetta G., Cappai, Roberto, Cherny, Robert A., Donnelly, Paul S., Hill, Andrew F., Finkelstein, David I., Barnham, Kevin J.·2012·Journal of Experimental Medicine

Abstract

Parkinson’s disease (PD) is a progressive, chronic disease characterized by dyskinesia, rigidity, instability, and tremors. The disease is defined by the presence of Lewy bodies, which primarily consist of aggregated α-synuclein protein, and is accompanied by the loss of monoaminergic neurons. Current therapeutic strategies only give symptomatic relief of motor impairment and do not address the underlying neurodegeneration. Hence, we have identified CuII(atsm) as a potential therapeutic for PD. Drug administration to four different animal models of PD resulted in improved motor and cognition function, rescued nigral cell loss, and improved dopamine metabolism. In vitro, this compound is able to inhibit the effects of peroxynitrite-driven toxicity, including the formation of nitrated α-synuclein oligomers. Our results show that CuII(atsm) is effective in reversing parkinsonian defects in animal models and has the potential to be a successful treatment of PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20112285

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 180

Metadata

Authors
Hung, L. W., Villemagne, V. L., Cheng, L., Sherratt, N. A., Ayton, S., White, A. R., Crouch, P. J., Lim, S., Leong, S. L., Wilkins, S., George, J., Roberts, B. R., Pham, C. L. L., Liu, X., Chiu, F. C. K., Shackleford, D. M., Powell, A. K., Masters, C. L., Bush, A. I., O’Keefe, G., Culvenor, J. G., Cappai, R., Cherny, R. A., Donnelly, P. S., Hill, A. F., Finkelstein, D. I., & Barnham, K. J.
Venue
Journal of Experimental Medicine
Published
2012-04-02
Volume
209
Issue
4
Pages
837-854
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2022745281
Cited by
180
References
8
FWCI
6.73
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease. https://app.cochat.ai/papers/10.1084/jem.20112285
The paper
Hung, L. W., Villemagne, V. L., Cheng, L., Sherratt, N. A., Ayton, S., White, A. R., Crouch, P. J., Lim, S., Leong, S. L., Wilkins, S., George, J., Roberts, B. R., Pham, C. L. L., Liu, X., Chiu, F. C. K., Shackleford, D. M., Powell, A. K., Masters, C. L., Bush, A. I., . . . Barnham, K. J. (2012). The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20112285

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.